Macquarie Group
OPTN

Macquarie Group’s OptiNose OPTN Stock Holding History

Macquarie Group’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-245
Closed -$3.82K – 1840
2024
Q2 		$3.82K Buy
+245
New +$4.1K ﹤0.01% 1747
2018
Q2 		– Sell
-1,790
Closed -$538K – 2253
2018
Q1 		$538K Sell
1,790
-16
-0.9% -$4.43K ﹤0.01% 1365
2017
Q4 		$512K Buy
+1,806
New +$508K ﹤0.01% 1439

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group's OPTN Position: Q3 2024 in Review

Macquarie Group sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 245 shares — an estimated $3.82K sold.

Macquarie Group first reported a position in OPTN in Q4 2017 and held it in 3 quarters. The position peaked at $538K in Q1 2018. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • Macquarie Group reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • Macquarie Group sold 245 OptiNose shares in Q3 2024, an estimated $3.82K.
  • Macquarie Group first reported a position in OptiNose in Q4 2017 and held it in 3 quarters.
  • Macquarie Group's OptiNose position peaked at $538K in Q1 2018.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.